AATM Monoclonal Antibody

Glutamic-oxaloacetic transaminase is a pyridoxal phosphate-dependent enzyme which exists in cytoplasmic and inner-membrane mitochondrial forms, GOT1 and GOT2, respectively. GOT plays a role in amino acid metabolism and the urea and tricarboxylic acid cycles. The two enzymes are homodimeric and show close homology. Two transcript variants encoding different isoforms have been found for this gene.

Introducing the AATM Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of immunotherapy. This meticulously engineered antibody showcases exceptional specificity and affinity towards its target antigen, ensuring unparalleled efficacy in disease treatment and diagnostics.

Crafted through a rigorous process of hybridoma fusion, the AATM Monoclonal Antibody exhibits remarkable stability and consistency, guaranteeing reproducible results across various applications. Its superior purity and low endotoxin levels further enhance its suitability for both in vitro and in vivo experiments, rendering it an indispensable tool for researchers and clinicians alike.

The AATM Monoclonal Antibody's exceptional binding affinity enables precise and accurate detection of its target antigen, facilitating early disease diagnosis and monitoring. Its robust performance in immunohistochemistry, flow cytometry, and Western blotting techniques ensures reliable and reproducible data acquisition, empowering researchers to unravel intricate biological mechanisms with utmost confidence.

Furthermore, the AATM Monoclonal Antibody's versatility extends beyond research applications, as it holds immense potential for therapeutic interventions. Its potent neutralizing capabilities against disease-associated antigens make it an invaluable asset in the development of targeted therapies, offering new avenues for the treatment of various debilitating conditions.

With its unrivaled quality, reliability, and versatility, the AATM Monoclonal Antibody stands at the forefront of scientific advancements, poised to revolutionize the landscape of immunotherapy. Embrace the future of biomedical research and clinical practice with this groundbreaking product, and unlock a world of possibilities in the pursuit of improved human health.